FDA Approves New Merkel Cell Carcinoma Drug Zynyz FDA Approves New Merkel Cell Carcinoma Drug Zynyz

The PD-1 inhibitor received accelerated approval for adults with metastatic or recurrent locally advanced Merkel cell carcinoma.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news